Australian expressed RNAi shop Benitec this week announced that it received a notice of allowance from the US Patent and Trademark Office for a patent application covering the use of multiple-promoter expression cassettes for simultaneous delivery of RNAi.

Separately last week, the company provided an update on its efforts to overcome rejections to its core US patent, stating that the USPTO won’t likely decide on a company appeal until the third quarter of next year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.